[Breaking] Government: "Pfizer and Moderna Vaccine Price Increase Likely to Affect Next Year's Contracts"

[Asia Economy Reporter Lim Juhyung] As U.S. pharmaceutical companies Pfizer and Moderna have raised the supply prices of their COVID-19 vaccines, South Korea is also expected to be affected starting from next year's contracts.

On the 2nd, Son Youngrae, head of the Social Strategy Division at the Central Disaster and Safety Countermeasures Headquarters (CDSCH), responded to related inquiries during a COVID-19 situation briefing, stating, "There may be an impact on the parts we are negotiating for contracts next year," and added, "Since we are currently in the early stages of negotiation, it is difficult to determine the actual impact, but it will be affected during the future negotiation process."

This content was produced with the assistance of AI translation services.